Ann Allergy Asthma Immunol

1. COUILLARD S, Petousi N, Ramakrishnan S, Valle R, et al
   Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asth
   Ann Allergy Asthma Immunol. 2026 Apr 10:S1081-1206(26)00150.
   

   >> Share

   
   
2. ABD AE, Trottier H, Tse SM, Masse B, et al
   Impact of vitamin D status and supplementation on exploratory inflammatory biomarkers in preschoolers with asthma.
   Ann Allergy Asthma Immunol. 2026 Apr 9:S1081-1206(26)00128.
   

   >> Share

   
   

   
   Arch Dis Child

3. MOHAMMED ABDUL WAJID L, Saglani S, Nagakumar P, Heath G, et al
   Exploring health professional views of management for preschool wheeze: a qualitative study.
   Arch Dis Child. 2026;111:444-448.
   

   >> Share

   
   

   
   Arerugi

4. HARIGANE R, Rikimaru M, Kume H
   [A CASE OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS THAT DEVELOPED FROM DE NOVO SENSITIZATION IN A STABLE NON-ATOPIC ASTHMA, DIAGNOSED BY COMPUTED TOMOGRAPHY].
   Arerugi. 2026;75:153-158.
   

   >> Share

   
   
5. ITOGA M, Oyama S, Nunomura Y, Fukushima T, et al
   [DIAGNOSIS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-NEGATIVE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS BASED ON RENAL PATHOLOGICAL FINDINGS WITHOUT ASTHMA].
   Arerugi. 2026;75:147-152.
   

   >> Share

   
   

   
   Chest

6. GRAVES JM, Krings JG
   Payer-Driven Inhaler Switching: An Underrecognized Threat to Asthma and COPD Care.
   Chest. 2026;169:867-869.
   

   >> Share

   
   
7. LOSIER A
   Fungal Sensitization and Bronchiectasis: Time for an Endotype-Based Approach?
   Chest. 2026;169:859-861.
   

   >> Share

   
   
8. PEIRCE AM, Hogan CK, Weinstein JB, Seelye SM, et al
   Clinician Views on Inhaler Substitution in the Veterans Health Administration.
   Chest. 2026;169:1039-1050.
   

   >> Share

   
   
9. SON E, Seo H, Ra SW, Park SJ, et al
   Clinical Outcomes in Patients With COPD With Disease Stability: Data from the Korea COPD Subgroup Study Cohort.
   Chest. 2026;169:958-967.
   

   >> Share

   
   

   
   Clin Exp Allergy

10. KOBAYASHI Y, Ho QD, Le NKT, Khuc LTT, et al
    The Clinical Value of Measuring Nasal Nitric Oxide in Addition to Exhaled Nitric Oxide in Asthma Associated With Eosinophilic Chronic Rhinosinusitis.
    Clin Exp Allergy. 2026 Apr 16. doi: 10.1111/cea.70305.
    

    >> Share

    
    

    
    J Asthma

11. SAINT-FLEUR AL, Cohen RT, Trivedi M, Sawicki GS, et al
    Clinician Perspectives on the Discontinuation of Brand Name Flovent in Pediatric Asthma Care.
    J Asthma. 2026 Apr 17:1-11. doi: 10.1080/02770903.2026.2660098.
    

    >> Share

    
    
12. ALAMI A, Little J, Zwerling AA, Abdul SA, et al
    Self-Perceived Mental Health Among Canadian Adolescents and Young Adults with Asthma: Insights from a National Cross-sectional Study.
    J Asthma. 2026 Apr 17:1-12. doi: 10.1080/02770903.2026.2660321.
    

    >> Share

    
    
13. MATSUNO O
    Baseline Blood Eosinophil Count Does Not Predict Short-Term Changes in Oscillometric Parameters in Steroid-Naive Asthma.
    J Asthma. 2026 Apr 17:1-13. doi: 10.1080/02770903.2026.2660094.
    

    >> Share

    
    
14. XU X, Gao S, Huang Z, Mao Y, et al
    Emerging Trends and Research Frontiers in Refractory Asthma: A Comprehensive Bibliometric Analysis from 2004 to 2025.
    J Asthma. 2026 Apr 15:1-13. doi: 10.1080/02770903.2026.2660324.
    

    >> Share

    
    
15. BOZEK A, Miodonska M, Sadowska D, Zalejska Fijolka J, et al
    Three years treatment with HDM allergen immunotherapy, omalizumab, or combination therapy in allergic asthma: clinical outcomes and biomarkers.
    J Asthma. 2026 Apr 15:1-18. doi: 10.1080/02770903.2026.2660096.
    

    >> Share

    
    
16. KALLIERI M, Papadopoulos NG, Zervas E, Exarchos K, et al
    Geographical variability in severe asthma: comparison of patients' characteristics between national, regional and international cohorts in ISAR.
    J Asthma. 2026 Apr 12:1-16. doi: 10.1080/02770903.2026.2654601.
    

    >> Share

    
    
17. LI M, Xu Y, Dai K, Tao L, et al
    Exogenous Compounds and Confounding Variables: Re-evaluating the Diagnostic Accuracy of Breath Metabolomics in Asthma and COPD.
    J Asthma. 2026 Apr 12:1-2. doi: 10.1080/02770903.2026.2654595.
    

    >> Share

    
    

    
    J Investig Allergol Clin Immunol

18. ALMONACID C, Davila I, Plaza V, Dominguez-Ortega J, et al
    Artificial Intelligence in Asthma: From Diagnosis to Management.
    J Investig Allergol Clin Immunol. 2026 Apr 10:0. doi: 10.18176/jiaci.1171.
    

    >> Share

    
    
19. BAPTISTA-SERNA L, De Las Heras-Gozalo M, Korshunova D, Santano E, et al
    Vitellogenin Identified as a Novel Allergen in Tenebrio molitor: Evidence from an Occupational Asthma Case.
    J Investig Allergol Clin Immunol. 2026 Apr 17:0. doi: 10.18176/jiaci.1175.
    

    >> Share

    
    

    
    Pediatr Allergy Immunol

20. ALI M, Horner D, Wang T, Brustad N, et al
    Western dietary pattern during pregnancy and early childhood increases risk of childhood asthma dependent on socioeconomic status.
    Pediatr Allergy Immunol. 2026;37:e70351.
    

    >> Share

    
    
21. MIAO Q, Hou X, Xiang L, Zhang T, et al
    Expanded peripheral CD62L(low) inflammatory eosinophils in pediatric thunderstorm-related asthma exacerbations: A single-center analysis.
    Pediatr Allergy Immunol. 2026;37:e70349.
    

    >> Share

    
    
22. MASEKELA R, Rutter CE, Mortimer K, Chiang CY, et al
    Environmental risk factors for allergic rhinitis differ by income level: A Global Asthma Network survey.
    Pediatr Allergy Immunol. 2026;37:e70332.
    

    >> Share

    
    

    
    Pediatr Pulmonol

23. GABBAY JM, Bajaj BVM, Levano SR, Wu AC, et al
    Predicting Pediatric Asthma Readmissions Through Machine Learning: Performance With a National Administrative Database.
    Pediatr Pulmonol. 2026;61:e71624.
    

    >> Share

    
    

    
    PLoS One

24. JAYASINGHE T, Issac H, Deravin L, Terry D, et al
    Digital referral experiences within Australian general practice: Insights from Chronic Obstructive Pulmonary Disease (COPD) care as an exemplar.
    PLoS One. 2026;21:e0344663.
    

    >> Share

    
    
25. LIU L, Sun Y, Wang Y, Xie X, et al
    Bioinformatics analysis and qRT-PCR validation of iron metabolism-related genes in pediatric asthma.
    PLoS One. 2026;21:e0346063.
    

    >> Share

    
    

    
    Pneumologie

26. LOMMATZSCH M, Buhl R, Taube C, Hamelmann E, et al
    [Clinical and economic role of FeNO measurements in adults with asthma].
    Pneumologie. 2026 Apr 16. doi: 10.1055/a-2834-1743.
    

    >> Share

    
    

    
    Respir Med

27. HUANG H, Liang H, Wang J, Gong Z, et al
    Type 2 biomarkers outperform asthma-COPD overlap definitions in predicting clinical outcomes in COPD patients initiating triple therapy: A prospective cohort study.
    Respir Med. 2026;257:108825.
    

    >> Share

    
    

    
    Respir Res

28. SEMENZATO U, Santello V, Fichera G, Previtero D, et al
    Quantitative computed tomography body composition analysis for risk stratification in bronchiectasis.
    Respir Res. 2026 Apr 17. doi: 10.1186/s12931-026-03670.
    

    >> Share

    
    
29. MAHE J, Muller G, Roche N, Bourdin A, et al
    Increasing propellant gas emissions from pressurized metered-dose inhalers in obstructive lung diseases in France over 11 years.
    Respir Res. 2026;27:171.
    

    >> Share

    
    
30. NIU W, Huang J, Hu Y, Tang G, et al
    Short-term effects of air pollutants on asthma hospitalizations in a megacity in North China (2016-2021): a time-series study.
    Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03620.
    

    >> Share

    
    
31. HUGO T, Harper AR, Leander J, Gardiner P, et al
    Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA).
    Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03613.
    

    >> Share

    
    

    
    Thorax

32. WILSON AM, Musgrave SD, Smith JR, Noble M, et al
    At-risk registers integrated into primary care to stop asthma crises in the UK: cluster randomised controlled trial with economic evaluation.
    Thorax. 2026 Apr 15:thorax-2025-223973. doi: 10.1136/thorax-2025-223973.
    

    >> Share

    
    
33. LAI CC, Chen CH, Wang YH, Wang CY, et al
    Association between overuse of short-acting beta2-agonists and the risk of major adverse cardiovascular events among patients with asthma.
    Thorax. 2026 Apr 15:thorax-2024-222204. doi: 10.1136/thorax-2024-222204.
    

    >> Share

    
    
34. POPOVIC M, Maule M, Moccia C, Isaevska E, et al
    Maternal eating disorders and respiratory outcomes in childhood: findings from the EU Child Cohort Network.
    Thorax. 2026;81:464-473.
    

    >> Share

    
    
35. SMITH TA, Roberts MM, Luckett T, Cho JG, et al
    Multidisciplinary, non-pharmacological breathlessness intervention service for patients with moderately severe to severe COPD: a randomised controlled trial.
    Thorax. 2026;81:420-429.
    

    >> Share

    
    
36. NAESILLA N, Quint JK, Zuber V
    Understanding the bidirectional relationship between chronic respiratory disease and cardiovascular disease using genetic evidence.
    Thorax. 2026;81:447-456.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share